PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24002992-1	2013	PURPOSE: The purpose of this study was to evaluate the clinical usefulness of partial volume effect (PVE)-corrected F-18 FDG PET/CT for predicting I-131 accumulation in metastatic lymph nodes (mLNs) during I-131 therapy for papillary thyroid carcinoma (PTC).	Iodine-131	147-152	mastermind like domain containing 1	Homo sapiens	116-120	
27275361-0	2016	Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody.	Iodine-131	81-92	mastermind like domain containing 1	Homo sapiens	23-27	
27275361-11	2016	CONCLUSIONS: F-18 FDG PET/CT, although less sensitive, showed high specificity, PPV, NPV, and accuracy and therefore can be useful for the patients with negative diagnostic radioiodine scan and elevated serum Tg or positive TgAb.	Iodine-131	173-184	mastermind like domain containing 1	Homo sapiens	13-17	
24002992-10	2013	CONCLUSION: PVE-corrected F-18 FDG PET/CT is a valuable predictor of I-131 accumulation in mLNs during RIT.	Iodine-131	69-74	mastermind like domain containing 1	Homo sapiens	26-30	
22228332-2	2012	An inverse relationship between I-131 and F-18 fluorodeoxyglucose (FDG) uptake in PET/CT ("flip-flop phenomenon") was described for thyroid cancers (TCs) during dedifferentiation.	Iodine-131	32-37	mastermind like domain containing 1	Homo sapiens	42-46	
32575591-2	2020	The purpose of this study is to evaluate the correlation between the mutation of the BRAF V600E oncogene and the pathological standardized uptake values (SUV) at the F18-fluorodeoxyglucose (F18-FDG) positron emission tomography/computed tomography (PET/CT) evaluation, for a group of 20 patients with radically treated (total thyroidectomy and radioiodine therapy) papillary thyroid cancer, with subclinical persistent disease, at 6 months after the initial treatment.	Iodine-131	344-355	mastermind like domain containing 1	Homo sapiens	166-169	
9777746-7	1998	In these patients F-18-FDG uptake increased with increasing antithyroid antibodies and shorter radioiodine half-life.	Iodine-131	95-106	mastermind like domain containing 1	Homo sapiens	18-22	
32575591-2	2020	The purpose of this study is to evaluate the correlation between the mutation of the BRAF V600E oncogene and the pathological standardized uptake values (SUV) at the F18-fluorodeoxyglucose (F18-FDG) positron emission tomography/computed tomography (PET/CT) evaluation, for a group of 20 patients with radically treated (total thyroidectomy and radioiodine therapy) papillary thyroid cancer, with subclinical persistent disease, at 6 months after the initial treatment.	Iodine-131	344-355	mastermind like domain containing 1	Homo sapiens	190-193